ArticleJournal of managed care & specialty pharmacy2016

Real-World Drug Costs of Treating Hepatitis C Genotypes 1-4 with Direct-Acting Antivirals: Initiating Treatment at Fibrosis 0-2 and 3-4.

Timothy A Bach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.